Gene · 84148
Papers2,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Framing Function: Metallophthalocyanine-Based Metal-Organic Frameworks as Multifunctional Materials for Electrified Devices. | Acc Mater Res | 2026 | 41783505 | PubTator, text mining | PubMed |
| Nicotine-induced mitophagy in bronchial epithelial cells and MYST1 downregulation in cigarette smoke-exposed lungs: potential mechanisms of COPD progression. | Mol Biol Rep | 2026 | 41779222 | PubTator, text mining | PubMed |
| Precisely Creating Enzyme-Mimetic Metal-Organic Framework for Unnatural Peptide Synthesis. | J Am Chem Soc | 2026 | 41776398 | PubTator, text mining | PubMed |
| Lactylation in urological malignancies: emerging mechanisms and therapeutic direction. | Front Cell Dev Biol | 2026 | 41768991 | PubTator, text mining | PubMed |
| Beneficial effects of a high-anthocyanin diet versus a Westernized diet on colorectal cancer risk: a systematic review. | Front Immunol | 2026 | 41766895 | PubTator, text mining | PubMed |
| Influence of Impregnation Conditions on Tenoxicam Solubility and Loading into γ-Cyclodextrin Metal-Organic Frameworks: A Box-Behnken Design Approach. | Pharmaceutics | 2026 | 41754948 | PubTator, text mining | PubMed |
| Leveraging Machine Learning for Screening Metal-Organic Frameworks with Selective CO2 Recognition for Early Thermal Runaway in Lithium-Ion Batteries. | Nanomaterials (Basel) | 2026 | 41745161 | PubTator, text mining | PubMed |
| Protocol for KAT8 conditional knockout mice generation and its application in 4NQO-induced esophageal tumor model. | STAR Protoc | 2026 | 41739644 | PubTator, text mining | PubMed |
| Assessing the Stability of Metal-Organic Frameworks with Local Vibrational Mode Theory. | J Phys Chem C Nanomater Interfaces | 2026 | 41737058 | PubTator, text mining | PubMed |
| Lactylation as a metabolic-epigenetic switch: Mechanisms and roles in cancer, sepsis, trauma, inflammation, and tissue repair. | Biochem Biophys Rep | 2026 | 41732414 | PubTator, text mining | PubMed |
| Biallelic DAW1 variants reveal tissue-specific role in heterotaxy without primary ciliary dyskinesia. | Res Sq | 2026 | 41727625 | PubTator, text mining | PubMed |
| Dual Recognition and Highly Sensitive Detection of ATP by Aptamer-Bridged MOF Functionalized Glass Nanopipette. | Anal Chem | 2026 | 41725432 | PubTator, text mining | PubMed |
| A MOF-Lanthanide Theranostic Agent with Bidirectional Near-Infrared Photon Conversion for Tumor-Responsive Therapy and Real-Time Imaging. | J Am Chem Soc | 2026 | 41725349 | PubTator, text mining | PubMed |
| Precise modulation of MOF pore structures via functional group dimensions and spatial configuration for membrane separation. | Sci Adv | 2026 | 41719401 | PubTator, text mining | PubMed |
| Multimodal Nanoscale Mapping of Local Structure and CO2 Adsorption in Metal-Organic Frameworks. | J Am Chem Soc | 2026 | 41718477 | PubTator, text mining | PubMed |
| Aluminium MOF as a selective sensor for atrazine with docking and computational insight. | RSC Adv | 2026 | 41717257 | PubTator, text mining | PubMed |
| Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting. | Clin Transl Med | 2026 | 41711048 | PubTator, text mining | PubMed |
| Commutative Algebra Modeling in Materials Science - A Case Study on Metal-Organic Frameworks (MOFs). | J Chem Inf Model | 2026 | 41701504 | PubTator, text mining | PubMed |
| Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. | Mol Biomed | 2026 | 41692895 | PubTator, text mining | PubMed |
| Microfluidic Printing-Induced Dynamic Splitting of Conductive MOF to Expose High-Density Active Sites for Boosted CO2 Electroreduction. | Small | 2026 | 41691631 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84148/papers?page=5